This document summarizes a key clinical trial called the Acute Renal Failure Trial Network Study (ATN) that compared intensive versus conventional renal replacement therapy (RRT) in critically ill patients with acute kidney injury (AKI) from acute tubular necrosis (ATN). The trial found that intensive RRT, with either 6 hemodialysis treatments per week or higher effluent flow rates with continuous RRT, did not decrease mortality at 60 days compared to conventional RRT with 3 hemodialysis treatments per week or lower effluent flow rates. Intensive RRT also did not improve renal function or other organ dysfunction, though it was associated with more hypotensive episodes. The trial provided evidence that a more